Comparative in vitro study of Coleus amboinicus and paclitaxel on oral cancer cells

体外比较研究毛喉鞘蕊花和紫杉醇对口腔癌细胞的影响

阅读:1

Abstract

BACKGROUND: Oral cancer still represents a leading cause of mortality in India. Due to the drawbacks and limitations of current treatment options, a safe, low-cost therapy is the need of the hour. Recently, newer plant extracts with anticancer properties have gained considerable attention. Coleus amboinicus has been studied for its anticancer effects against various cancers. However, research focusing specifically on its effects on oral cancer cells is limited, highlighting the importance of this study. AIMS: The study intends to evaluate the anticancer effects of ethanolic leaf extract of Coleus amboinicus against CAL 27 cell lines through in vitro assays and to compare this with the previously existing plant-derived anticancer drug used for oral cancer, paclitaxel. MATERIALS AND METHODS: Ethanolic extracts of leaves of Coleus amboinicus were prepared, and the anticancer efficacy of the leaf extract as well as paclitaxel was evaluated against CAL-27 oral cancer cells in vitro. MTT assay was performed using various concentrations of the plant extract and the drug on oral cancer cells. The percentage of cell viability for each concentration was calculated, and the IC(50) values were derived for both the extracts. Apoptosis detection was done using acridine orange-ethidium bromide dual fluorescence staining. RESULTS: The results revealed a decrease in the percentage of viable cells with increasing concentration of Coleus amboinicus extracts. The IC(50) values of Coleus amboinicus and paclitaxel were 206.44 and 54.97 µg/ml, respectively (P < 0.001). Coleus amboinicus showed significant cytotoxicity, although not as effective as paclitaxel, on oral cancer CAL-27 cells. CONCLUSION: The leaves of Coleus amboinicus exhibit potent anticancer activity against oral cancer (CAL-27) cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。